Nonetheless, the serum expression level of lncRNA-H19 levels in CIS patients (23.19 ± 20.87, mean ± SD) was significantly higher than in healthy controls at p = 0.0001 (Table 7). The gene discussed is H19; the disease is in situ carcinoma.